As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and
As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and
As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and
As the complexity and importance of screening, testing, and individualized treatment strategies for breast cancer have increased, so has clinicians’ reliance on the National Comprehensive Cancer Network (NCCN) Breast Cancer Guidelines and NCCN’s educational interventions to increase knowledge and
Join Leora Horn, MD, MSc, FRCPC and Christine Lovly, MD, PhD as they present their multidisciplinary expertise on a range of cases pertaining to biomarker driven advanced disease lung cancer.
Join Kristine Kokeny, MD and John Ward, MD as they present their multidisciplinary expertise on a range of cases pertaining to adjuvant systemic therapy for breast cancer.
Join Jason Rockhill, MD and John Thompson, MD as they present their multidisciplinary expertise on a range of cases pertaining to advanced disease melanoma.